FAR Publishing Limited Jul 31 2025 In a breakthrough for cardiovascular medicine, researchers have harnessed artificial intelligence to discover unexpected lipid-lowering effects in existing FDA-approved drugs. The study, published in Acta Pharmacologica Sinica , addresses critical gaps in hyperlipidemia treatment-where many patients struggle with intolerance or inadequate response to statins and other standard therapies. Using a novel machine learning framework, the team analyzed 3,430 drugs (